Skip to main content
Clinical Trials/NCT02336581
NCT02336581
Completed
Not Applicable

Effectiveness of Psychosocial Treatment for Inpatients With Psychosis

Butler Hospital1 site in 1 country62 target enrollmentMarch 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psychosis
Sponsor
Butler Hospital
Enrollment
62
Locations
1
Primary Endpoint
Brief Psychiatric Rating Scale
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

To test the effectiveness of Acceptance and Commitment Therapy (ACT) versus enhanced Treatment as Usual (eTAU) delivered by hospital staff for inpatients with psychotic-spectrum disorders.

Detailed Description

Patients with psychotic disorders frequently require treatment at inpatient hospital settings during periods of acute illness for crisis management and stabilization. Although these patients often receive efficacious pharmacotherapy, there is a recognized lack of empirically-supported psychosocial interventions provided to patients in typical hospital settings. The provision of high quality psychosocial treatment during hospitalization is challenging due to short lengths of stay and a general lack of trained therapist employed on hospital units who can provide these evidence-based therapies. This unmet need for hospital psychosocial treatment represents a crucial missed opportunity to teach patients coping strategies that can speed time to recovery and impact post-discharge risk factors. Acceptance and Commitment Therapy (ACT) is a newer cognitive-behavioral approach that combines innovative mindfulness-based strategies for helping patients to cope more successfully with psychotic and other symptoms and implement values-consistent behavioral goals. However, adaptations to the original ACT approach are urgently needed to foster widespread implementation in community settings. The aim of the current study is to adapt the only promising acute-care psychosocial treatment for psychosis to be implementable in an inpatient setting and pilot test its effectiveness.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
September 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Brandon Gaudiano

Research Psychologist/Associate Professor

Butler Hospital

Eligibility Criteria

Inclusion Criteria

  • current psychiatric hospitalization
  • diagnosis of schizophrenia, schizoaffective disorder, schizophreniform, brief psychotic disorder, delusional disorder, specified/unspecified other psychotic disorder, or a diagnosis of a mood disorder (major depressive disorder or bipolar disorder) with psychotic features, as determined by chart review and confirmed by the Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)-5
  • 18 years or older
  • ability to speak and read English.

Exclusion Criteria

  • psychosis severe enough to prevent participation in regular hospital groups
  • psychotic disorder related to a general medical condition or substance-induced psychotic disorder
  • significant cognitive impairment (mini-mental state exam score \< 15).

Outcomes

Primary Outcomes

Brief Psychiatric Rating Scale

Time Frame: Hospital Discharge (1 Week)

Secondary Outcomes

  • Psychiatric Rehospitalization(4 Months Post-Discharge)

Study Sites (1)

Loading locations...

Similar Trials